Warden Charles M

Avg. Two Year Performance

No purchase track record

53% Avg. Sale Return

24% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(3%)	22%	60%	71%	53%
Sale Success Rate	0 of 1	1 of 1	1 of 1	1 of 1	1 of 1

Ocular Therapeutix, Inc

Drugs » Biotechnology

Director:

Holdings: 72.46K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--